| Bid price | 1,417.00 | Open price | 1,410.50 |
|---|---|---|---|
| Ask price | 1,417.50 | Prev close | 1,417.00 |
| High price | 1,427.75 | Spread | 0.04% |
| Low price | 1,408.00 | Volume | 7,763,777 |
Register now for FREE live GlaxoSmithKline share prices, GlaxoSmithKline stock quotes, charts, trades and FREE GlaxoSmithKline company fundamentals, market news and much much more. Why not upgrade to a premium service and get GlaxoSmithKline Level 2 Data, indepth research tools and investor commentary for GlaxoSmithKline (GSK) and other London Stock Exchange equities.
Register now for FREE GlaxoSmithKline share price charts
| Name | GlaxoSmithKline | Epic | GSK |
|---|---|---|---|
| Activites | Pharmaceuticals accounted for 84% of 2008 revenues and Consumer Healthcare, 16% | Reuters | GSK.L |
| ISIN | GB0009252882 | Google Finance | LON:GSK |
| Share Price (p) | 1,417.00 | Prev. Share Price (p) | 1,417.00 |
|---|---|---|---|
| Shares in Issue (m) | 5,029 | Market Cap (£m) | 70,877 |
| PE Ratio (x) | 14.07 | Div per share (p) | 21.00 |
| Div yield (%) | 5.06 | Div cover (x) | 1.55 |
| EPS (p) | 104.60 | PEG | 3.35 |
Register now for FREE GlaxoSmithKline company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 11/05/2012 | BUY | Andrew Witty | CEO | 9 |
| 11/05/2012 | BUY | Simon Dingemans | FD | 9 |
| 08/05/2012 | BUY | Andrew Witty | CEO | 54 |
| 26/04/2012 | TOUT | Andrew Witty | CEO | 1,000 |
| 20/04/2012 | DRI | Andrew Witty | CEO | 19,276 |
/* */ RNS Number : 1783E GlaxoSmithKline PLC 25 May 2012 GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2012 it purchased 1,800,000 of its Ordinary...
/* */ RNS Number : 0841E GlaxoSmithKline PLC 24 May 2012 GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2012 it purchased 1,800,000 of its Ordinary...
/* */ RNS Number : 9865D GlaxoSmithKline PLC 23 May 2012 GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2012 it purchased 1,800,000 of its Ordinary...
More GlaxoSmithKline Company News >>
Register now for FREE GlaxoSmithKline company news
there seems to be some heavy resistance around these level with a lot of potential upside.
UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1...
UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1...
Register now for FREE GlaxoSmithKline share price discussions